Sorry, you must have the wrong number http://lamalinks.fun lamalinks Researchers and patient groups want access to this raw datato improve third-party scrutiny and stress-test claims aboutdrugs. But many companies fear that this will damage theirbusinesses and undermine the ability to defend patents.
